Inception Capital Management is a venture capital firm specialising in private equity of emerging
brand name technology companies and cancer biotech companies. They manage several venture
capital funds. Currently, they are excited and busy with their underwriters at Network 1 Financial preparing Genprex (www.genprex.com) for a potential IPO on Nasdaq in Q1 2017 after 3 years of development
and clinical trials in stage 4 lung cancer with great results.
ClearlySo, Europe’s leading impact investment bank, announced today that it has launched ClearlySo ATLAS, an impact assessment solution for private equity and venture capital investors. Octopus Ventures, a London based venture capital firm, focused on backing unusually talented entrepreneurs, is the first customer to go-live and is in the process of rolling out the solution across its portfolio.
At Privet Capital we look to do special situations investing which involves unusual deals where there are issues within the business or the transaction which makes it more challenging for strategic investors or mainstream private equity firms.
Investor confidence in private equity investment is high, with 63% intending to invest in SMEs in the next five years and over half of UK investors looking to EIS for 2016.
Since the formative transaction that created C-III Capital Partners in 2010, C-III has grown into a fully-diversified commercial real estate services and investment management company; this full-service platform has a competitive advantage in sourcing, underwriting and managing real estate debt and equity investments.
Auscap is a value-based long short manager, looking to invest in quality companies that generate substantial cash flows and have a sustainable comparative advantage when they are trading at attractive prices.
Charlemagne Capital, the emerging markets equities specialist, has won two new segregated regional emerging market equity mandates together worth over US$100m.
Affiliated Managers Group, Inc., a global asset management company, has entered into a definitive agreement to acquire an equity interest in Ivory Investment Management, L.P.
Green Key Technologies, winner of the 2015 most promising sell-side start up award and maker of patented voice software designed specifically for traders and brokers, today announced that Chicago-based trading firms DRW and Eagle Seven have become equity owners.
Ogier has announced the appointment of Bryon Rees as a partner in its market-leading funds and corporate practice in Guernsey.
KSL Capital Partners, LLC announces that it has completed the final closing of its latest travel and leisure focused private equity fund, KSL Capital Partners IV, L.P., with total commitments of $2.677 billion, including the commitment of the General Partner.
There have been deepening losses in emerging markets on Wednesday, following poor Chinese manufacturing data showing activity reaching a 6 ½ year low.
This follows warnings yesterday from the Bank of England that the International Monetary Fund needs more resources and better tools to help emerging economies deal with the spill-over from slowing growth and future interest rate rises in advanced economies.
Health Care REIT, Inc. announced it has successfully completed its offering of $750 million in aggregate principal amount of 4.0% senior unsecured notes due June 1, 2025.
Press Ganey Holdings, Inc. today announced the pricing of its initial public offering of 8,900,000 shares of common stock at a public offering price of $25.00 per share.
NephroGenex, Inc., a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that it has commenced an underwritten public offering of shares of its common stock and expects to raise gross proceeds of up to $30 million. In addition, NephroGenex expects to grant the underwriters a 30-day option to purchase up to an additional $4.5 million of shares of its common stock in connection with the offering. All of the shares in the offering will be sold by NephroGenex.
Rare Element Resources Ltd., announced that it has closed its $3.4 million offering of common shares and warrants in a registered direct offering in the United States that resulted in net proceeds, after expenses, of approximately $3.2 million.
Registered in England and Wales.
1st Floor, Suite F,
1-2 Wetmore Road,
Burton on Trent
Staffordshire, DE14 1LS